Central BP device drops meds

A study from the Menzies Research Institute followed 286 patients with uncomplicated hypertension receiving both traditional arm-cuff monitoring of brachial BP and additional monitoring of central BP with the pen-like SphygmoCor device.

Half of the group had therapeutic decisions guided by the central BP measurements with the rest treated with usual care, according to brachial BP.

At the end of the 12-month study, antihypertensive daily dose medication was significantly reduced in the intervention group (15.4%) compared to usual care (2.6%).